News

Chris Driver, Senior Director, Product Management, Patient Suite, IQVIA

The convergence of AI, decentralized technologies, behavioral science, and real-world evidence opens the door to a new era in which the clinical trial industry proactively addresses participation barriers, integrates social determinants of health, and reimagines patient centricity.

Image Credit: Adobe Stock Images/Paulista. Survey findings reveal sponsor frustrations with change orders, turnover, and cost structures, while also underscoring the growing value placed on flexibility, quality deliverables, and collaborative partnerships.

Interviews with biopharma leaders and outsourcing partners reveal emerging trends in clinical trial resourcing models, highlighting a shift away from traditional full-service CRO arrangements toward hybrid strategies that balance in-house expertise, trusted consultants, and selective outsourcing.